Immunome (IMNM) Insider Trading & Ownership $21.66 -1.30 (-5.66%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$21.80 +0.14 (+0.63%) As of 05/22/2026 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunome (NASDAQ:IMNM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.21%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$1.63MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$11.30M Get IMNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMNM Insider Buying and Selling by Quarter Immunome Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2026Jean Jacques BienaimeDirectorBuy5,000$20.70$103,500.00 4/2/2026Jack HigginsInsiderSell9,438$21.64$204,238.32 4/2/2026Max RosettCFOSell65,000$21.92$1,424,800.00 3/23/2026Philip WagenheimDirectorSell28,200$20.65$582,330.00 3/20/2026Philip WagenheimDirectorSell36,800$20.47$753,296.00 3/11/2026Jean Jacques BienaimeDirectorBuy1,000$21.55$21,550.00 12/30/2025Clay B SiegallCEOBuy4,729$21.15$100,018.35 12/22/2025Isaac BarchasDirectorSell383,200$21.74$8,330,768.00 12/19/2025Clay B SiegallCEOBuy7,278$20.48$149,053.44 12/19/2025Philip TsaiInsiderBuy10,000$20.49$204,900.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/18/2025Clay B SiegallCEOBuy46,511$21.50$999,986.50 6/3/2025Jean Jacques BienaimeDirectorBuy5,000$9.38$46,900.00 (Data available from 1/1/2013 forward) IMNM Insider Trading Activity - Frequently Asked Questions Who is on Immunome's Insider Roster? The list of insiders at Immunome includes Bruce Turner, Clay B Siegall, Isaac Barchas, Jack Higgins, Jean Jacques Bienaime, Max Rosett, Philip Tsai, Philip Wagenheim, and Robert Lechleider. Learn more on insiders at IMNM. What percentage of Immunome stock is owned by insiders? 7.21% of Immunome stock is owned by insiders. Learn more on IMNM's insider holdings. Which Immunome insiders have been buying company stock? The following insiders have purchased IMNM shares in the last 24 months: Clay B Siegall ($4,041,201.07), Jean Jacques Bienaime ($327,000.00), Philip Tsai ($506,496.00), and Robert Lechleider ($149,831.40). How much insider buying is happening at Immunome? Insiders have purchased a total of 495,780 IMNM shares in the last 24 months for a total of $5,024,528.47 bought. Which Immunome insiders have been selling company stock? The following insiders have sold IMNM shares in the last 24 months: Isaac Barchas ($8,330,768.00), Jack Higgins ($253,327.64), Max Rosett ($1,655,023.80), and Philip Wagenheim ($1,335,626.00). How much insider selling is happening at Immunome? Insiders have sold a total of 540,542 Immunome shares in the last 24 months for a total of $11,574,745.44 sold. Immunome Active InsidersPurnanand D. Sarma (Age 61)CEOClay B Siegall (Age 65)CEO3 recent tradesMax Rosett (Age 36)CFO1 recent tradesMichael LefenfeldDirectorMichael RappDirectorJean Jacques BienaimeDirector2 recent tradesPhilip TsaiCTO1 recent tradesIsaac BarchasDirector1 recent tradesPhilip WagenheimDirector2 recent tradesBruce TurnerInsiderJack Higgins (Age 46)Insider1 recent tradesRobert Lechleider (Age 64)Insider More Insider Trading Tools from MarketBeat Related Companies CYTK Insider Trading ABVX Insider Trading KRYS Insider Trading IBRX Insider Trading NUVL Insider Trading PCVX Insider Trading KYMR Insider Trading PTGX Insider Trading SYRE Insider Trading MIRM Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:IMNM) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
